A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects

Clinical trial NCT07057726 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07057726
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability in Healthy Volunteers

Start date: 2024-10-09
Primary completion: 2025-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.